Lead Researcher Spotlight Professor Frank Ng, PhD Department of Biochemistry and Molecular Biology Monash University, Melbourne, Australia Professor Frank Ng led the pioneering research team that developed AOD-9604 in the 1990s as part of efforts to create a targeted anti-obesity therapeutic derived from human growth hormone
Its effects make it beneficial for individuals suffering from anxiety-related cognitive impairment and inflammation
From facial applications to scalp and specialty-use formulations, our expanding GHK-Cu portfolio allows providers to align treatment approaches with individual patient needs
Gently swirl, do not agitate: Once all BAC water is added, gently swirl the vial in slow circles until the powder fully dissolves
Pegvisomant is a modified version of human GH that has a much higher half-life than GH and acts as a competitive antagonist of the GHR 42, 43
As per the user manual, the MCID thresholds for SF-36 PCS and MCS are 3.8-point and 4.6-point increases, respectively